Cargando…

Effectiveness and feasibility of cardiovascular disease personalized prevention on high polygenic risk score subjects: a randomized controlled pilot study

AIMS: The aim of this study was to evaluate the effect of the intervention by proactively sharing a patient’s high polygenic risk score (PRS) for coronary artery disease (CAD). Outcomes included: (i) reduction in cardiovascular disease (CVD) risk factors over 12 months; (ii) difference in purchased...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viigimaa, Margus, Jürisson, Mikk, Pisarev, Heti, Kalda, Ruth, Alavere, Helene, Irs, Alar, Saar, Aet, Fischer, Krista, Läll, Kristi, Kruuv-Käo, Krista, Mars, Nina, Widen, Elisabeth, Ripatti, Samuli, Metspalu, Andres
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803971/ https://www.ncbi.nlm.nih.gov/pubmed/36600884 http://dx.doi.org/10.1093/ehjopen/oeac079

Ejemplares similares

Prevalence of chronic conditions and multimorbidity in Estonia: a population-based cross-sectional study
por: Jürisson, Mikk, et al.
Publicado: (2021)

Physical-mental health comorbidity: A population-based cross-sectional study
por: Jürisson, Mikk, et al.
Publicado: (2021)

Integration of questionnaire-based risk factors improves polygenic risk scores for human coronary heart disease and type 2 diabetes
por: Tamlander, Max, et al.
Publicado: (2022)

Risk of SARS-CoV-2 infection and hospitalization in individuals with natural, vaccine-induced and hybrid immunity: a retrospective population-based cohort study from Estonia
por: Uusküla, Anneli, et al.
Publicado: (2023)

Systematic comparison of family history and polygenic risk across 24 common diseases
por: Mars, Nina, et al.
Publicado: (2022)

Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification
por: Läll, Kristi, et al.
Publicado: (2019)

A retrospective cohort study of incidence and risk factors for severe SARS-CoV-2 breakthrough infection among fully vaccinated people
por: Meister, Tatjana, et al.
Publicado: (2023)

Ancestry deconvolution and partial polygenic score can improve susceptibility predictions in recently admixed individuals
por: Marnetto, Davide, et al.
Publicado: (2020)

Long-term mortality following SARS-CoV-2 infection: A national cohort study from Estonia
por: Uusküla, Anneli, et al.
Publicado: (2022)

Comparing distributions of polygenic risk scores of type 2 diabetes and coronary heart disease within different populations
por: Reisberg, Sulev, et al.
Publicado: (2017)

Polygenic Hyperlipidemias and Coronary Artery Disease Risk
por: Ripatti, Pietari, et al.
Publicado: (2020)

The role of polygenic risk and susceptibility genes in breast cancer over the course of life
por: Mars, Nina, et al.
Publicado: (2020)

Recall by genotype and cascade screening for familial hypercholesterolemia in a population-based biobank from Estonia
por: Alver, Maris, et al.
Publicado: (2018)

The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study
por: Jürisson, Mikk, et al.
Publicado: (2017)

Erratum to: The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study
por: Jürisson, Mikk, et al.
Publicado: (2017)

Personalized risk prediction for type 2 diabetes: the potential of genetic risk scores
por: Läll, Kristi, et al.
Publicado: (2017)

Factors influencing quality of life of people living with HIV in Estonia: a cross-sectional survey
por: Rüütel, Kristi, et al.
Publicado: (2009)

Improved treatment and prognosis after acute myocardial infarction in Estonia: cross-sectional study from a high risk country
por: Saar, Aet, et al.
Publicado: (2015)

Demographic associations for autoantibodies in disease-free individuals of a European population
por: Haller-Kikkatalo, Kadri, et al.
Publicado: (2017)

Polygenic Score for Physical Activity Is Associated with Multiple Common Diseases
por: SILLANPÄÄ, ELINA, et al.
Publicado: (2022)

Human essential hypertension: no significant association of polygenic risk scores with antihypertensive drug responses
por: Sánez Tähtisalo, Heini, et al.
Publicado: (2020)

Post-acute sequelae of COVID-19 among hospitalized patients in Estonia: Nationwide matched cohort study
por: Tisler, Anna, et al.
Publicado: (2022)

From genetic discovery to future personalized health research
por: Palotie, Aarno, et al.
Publicado: (2013)

Implementation of Risk-Stratified Breast Cancer Prevention With a Polygenic Risk Score Test in Clinical Practice
por: Padrik, Peeter, et al.
Publicado: (2023)

Clinical characteristics and risk factors for COVID-19 infection and disease severity: A nationwide observational study in Estonia
por: Meister, Tatjana, et al.
Publicado: (2022)

Antibiotic prescription preferences in paediatric outpatient setting in Estonia and Sweden
por: Lass, Jana, et al.
Publicado: (2013)

The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients
por: DeVries, J Hans, et al.
Publicado: (2023)

Precise, Genotype-First Breast Cancer Prevention: Experience With Transferring Monogenic Findings From a Population Biobank to the Clinical Setting
por: Jürgens, Hannes, et al.
Publicado: (2022)

Linking a Population Biobank with National Health Registries—The Estonian Experience
por: Leitsalu, Liis, et al.
Publicado: (2015)

A Breast Cancer Polygenic Risk Score Is Feasible for Risk Stratification in the Norwegian Population
por: Akdeniz, Bayram Cevdet, et al.
Publicado: (2023)

Disclosing Pharmacogenetic Feedback of Caffeine via eHealth Channels, Assessment of the Methods and Effects to Behavior Change: A Pilot Study
por: Alev, Kerti, et al.
Publicado: (2021)

Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999–2014
por: Hatswell, Anthony J, et al.
Publicado: (2016)

Intensity of end-of-life health care and mortality after systemic anti-cancer treatment in patients with advanced lung cancer
por: Oselin, Kersti, et al.
Publicado: (2021)

Validating the doubly weighted genetic risk score for the prediction of type 2 diabetes in the Lifelines and Estonian Biobank cohorts
por: Pärna, Katri, et al.
Publicado: (2020)

Cesarean section trends from 1992 to 2016 in Estonia and Finland: A registry‐based study
por: Sildver, Kaire, et al.
Publicado: (2023)

Predictors of quality of life of patients with type 2 diabetes
por: Kalda, Ruth, et al.
Publicado: (2008)

Polygenic burden has broader impact on health, cognition, and socioeconomic outcomes than most rare and high-risk copy number variants
por: Saarentaus, Elmo Christian, et al.
Publicado: (2021)

The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia
por: Uusküla, Anneli, et al.
Publicado: (2013)

Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification
por: Olsen, Maria, et al.
Publicado: (2021)

Hypertension and Reproduction
por: Nilsson, Peter M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4o1ils84mse31goo3g92k0pv5j